• Aprotinin (BPTI): Mechanism and Research Use

  2026-10-01

  Aprotinin, or bovine pancreatic trypsin inhibitor (BPTI), is a reversible serine protease inhibitor that targets trypsin, plasmin, and kallikrein. Its fibrinolysis inhibition supports research on perioperative blood loss reduction and cardiovascular surgery blood management, while assay-specific potency, formulation behavior, and clinical safety history require careful interpretation.

• ML133 HCl: Kir2.1 Research Workflow

  2026-09-30

  ML133 HCl is a selective potassium channel inhibitor for separating Kir2.1-dependent effects from broader potassium-channel activity. Its strongest applied use is mechanistic pulmonary artery smooth muscle cell proliferation research, where pharmacology can be paired with migration, protein-expression, and signaling assays.

• PX-478 2HCl: HIF-1α Workflow & Applications

  2026-09-29

  PX-478 2HCl provides a chemically timed way to suppress HIF-1α across paired normoxic and hypoxic assays, with practical value in cancer-cell signaling, radiosensitization, and ischemia-reporter studies. A 2024 prenatal-hypoxia study also shows how the inhibitor can connect molecular readouts with behavioral and tissue-level outcomes, while emphasizing timing-dependent safety evaluation.

• Protease Inhibitor Cocktail for Wnt Workflows

  2026-09-29

  Protect Wnt receptor-complex samples from rapid proteolysis without introducing EDTA that can disrupt divalent-cation-sensitive assays. This workflow shows how an EDTA-free 100X DMSO formulation supports lysate preparation, co-immunoprecipitation, phosphorylation analysis, and kinase assay development.

• Protease Inhibitor Cocktail for Signaling Assays

  2026-09-28

  Learn how a Protease Inhibitor Cocktail improves protein degradation prevention and strengthens interpretation of bioenergetic, ER-stress, Western blot, and co-immunoprecipitation assays. This article translates findings from a ciclopirox NSCLC study into practical sample-preservation decisions.

• SARS-CoV-2 Variant Shifts in ACE2 Receptor Use

  2026-09-28

  Shukla and colleagues developed a barcoded pseudovirus assay to compare how six SARS-CoV-2 spike proteins use a multiplexed library of 30 ACE2 sequences. Their results show that variant-associated changes have modest effects on human ACE2 compatibility but can substantially alter compatibility with animal orthologs, highlighting the value of testing host and viral sequence variation together.

• AZ505: A Selective SMYD2 Inhibitor for Research

  2026-09-27

  AZ505 is a substrate-competitive SMYD2 inhibitor that blocks access to the enzyme’s peptide-substrate groove without competing with SAM. Product information reports biochemical potency and selectivity, while a cisplatin-induced kidney disease study provides preclinical evidence that pharmacological SMYD2 inhibition can reduce renal fibrosis and inflammation.

• PFHxS Disrupts Zebrafish Lipid Homeostasis via PPARα

  2026-09-26

  An integrated lipidomic and transcriptomic study found that environmentally relevant PFHxS exposures altered multiple lipid classes and PPAR-related pathways in zebrafish larvae. Molecular simulation and antagonist coexposure support PPARα as a potential initiating target, while the evidence does not establish it as the sole cause of the observed lipid changes.

• Sodium Oxamate: Reliable Assay Design

  2026-09-25

  Learn how Sodium Oxamate (SKU C3893) can help investigate LDH-A-dependent metabolism without mistaking metabolic readout changes for altered cell number. This scenario-driven guide covers assay compatibility, dose-finding, interpretation, and practical product-selection criteria.

• Mycobacterium tuberculosis WecA: Expression and Kinetics

  2026-09-25

  The study establishes a practical route to produce and analyze the challenging membrane enzyme WecA, using regulated expression in Escherichia coli, affinity purification, mass-spectrometric identification, and UMP-based activity detection. Its kinetic analysis identifies tunicamycin as a competitive inhibitor and provides an experimental foundation for WecA mechanism studies and inhibitor discovery, while leaving important questions about assay conditions and inhibitor behavior for further work.

• Wnt3a Dimer Organizes the Extracellular Signalosome

  2026-09-24

  Cryo-EM structures show how a Wnt3a homodimer organizes Frizzled and LRP6 into a 2:4:2 extracellular complex, while interface mutations connect dimer formation to receptor clustering and downstream signaling. The findings provide a structural framework for understanding canonical Wnt activation and for investigating the Wnt–LRP6 interface.

• CD80 and 4-1BBL mRNA T-Cell Vaccine Findings

  2026-09-24

  Cho et al. reported that expanded CD4 T cells expressing both CD80 and 4-1BBL produced stronger CD8 T-cell responses than cells expressing either ligand alone, with antitumor activity in mouse tumor models. The poster supports a cellular-vaccine strategy worth testing further, while its limited methodological detail and preclinical scope constrain translation.

• UBE2F–SAG Neddylation Activates RHEB in Liver Tumors

  2026-09-24

  The study identifies RHEB as a non-cullin substrate of the UBE2F–SAG neddylation machinery and links modification at K169 to stronger mTORC1 signaling. Cell and liver-model findings connect this mechanism to steatosis and tumorigenesis following Pten loss, while patient data show an association between UBE2F, mTORC1 activity, and hepatocellular carcinoma survival.

• TMRE mitochondrial membrane potential assay kit Guide

  2026-09-23

  Use TMRE to convert mitochondrial polarization into a quantitative red-fluorescence readout for apoptosis, necrosis, and energy-stress studies. This workflow emphasizes CCCP validation, sodium-driven mitochondrial disruption, scalable plate formats, and troubleshooting that separates true depolarization from handling artifacts.

• Human iPSC Sensory Neurons for HSV-1 Latency

  2026-09-22

  Oh et al. developed a scalable human iPSC-derived sensory neuron system that supports HSV-1 latency and stimulus-induced reactivation. The model combines neuronal functional validation with virological, transcriptional, and chromatin-based criteria, providing a human-relevant platform for studying latency mechanisms and candidate interventions.

8399 records 1/560 page Next 12345 下5页 Last page